#Open journalism No news is bad news

Your contributions will help us continue to deliver the stories that are important to you

Support The Journal
Dublin: 13°C Saturday 19 September 2020

Pfizer cancels €400m expansion at Dublin plant

The plan was dependent on the success of a new cholesterol-reducing drug.

Image: Pfizer

PFIZER HAS CANCELLED a planned €400 million expansion at its Grange Castle plant in Clondalkin, Dublin.

The pharmaceutical company didn’t formally announce the investment, but recently sought planning permission for the development of the site.

In a statement it said the proposal was dependent on the success of clinical trials of bococizumab, a cholesterol-reducing drug.

The extension would have created 350 permanent jobs and over 1,000 roles during construction.

Grange Castle Grange Castle Source: Pfizer

A spokesperson for Pfizer said: “Following the decision to discontinue the development of bococizumab, part of the potential expansion for which the planning permission was sought will not now go ahead.

Expansion in relation to other incoming products will continue as planned involving investment, recruitment and new technology.

“Current and future development at Grange Castle, which is one of Pfizer’s leading biotechnology sites manufacturing a broad portfolio of biologic medicines and vaccines, is based on a number of commercialised products and pipeline compounds.”

Pfizer employs more than 3,000 people at plants in Dublin, Kildare, Cork and Sligo.

Read: Fine Gael is most popular party as Fianna Fáil loses ground

Read: Top Irish PR body seeks to curb rogue ‘influencers’ being paid to sell products and not admitting it

About the author:

Órla Ryan

Read next: